[Federal Register Volume 87, Number 45 (Tuesday, March 8, 2022)]
[Notices]
[Pages 12964-12965]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-04790]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Award of a Single-Source Cooperative Agreement To Fund 
Institut Pasteur de Cote d'Ivoire (IPCI)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), located 
within the Department of Health and Human Services (HHS), announces the 
award of approximately $1,000,000, for Year 1 of funding to the IPCI to 
sustain decentralization of HIV-associated microbiology at regional 
hospitals and to expand interventions to additional

[[Page 12965]]

regional hospitals. The award will improve support to and the 
coordination of the TB and OIs laboratory network for quality assured 
diagnosis of TB/DR-TB, including smear microscopy (LED), 
Lipoarabinomannan Assay (LF-LAM) for the diagnosis and screening of 
active tuberculosis in people with HIV, solid and liquid culture, and 
molecular WHO-recommended diagnostic tests (LIPA, Xpert Ultra). Funding 
amounts for years 2-5 will be set at continuation.

DATES: The period for this award will be September 30, 2022 through 
September 29, 2027.

FOR FURTHER INFORMATION CONTACT: Titania Techeira, Center for Global 
Health, Centers for Disease Control and Prevention, CDC C[ocirc]te 
d'Ivoire, U.S. Embassy B.P. 730 Abidjan Cidex 03, Telephone: 800-232-
6348, Email: [email protected].

SUPPLEMENTARY INFORMATION: The single-source award will strengthen IPCI 
as the National Reference Laboratory for TB and microbiology tests. 
This will enable IPCI to better and further sustain the efforts in 27 
Anti-Tuberculosis Centers (CATs) and in 16 regional reference 
laboratories previously supported for decentralized microbiology 
diagnosis.
    IPCI is in a unique position to conduct this work as it is the 
designated laboratory institution in charge of integrated Disease 
Surveillance and Response (IDSR) in Cote d'Ivoire by the Ministry of 
Health (MOH) and Ministry of Scientific Research. IPCI is responsible 
for the implementation, monitoring, and evaluation of population-based 
TB, malaria and epidemic disease surveillance, including HIV 
opportunistic infections, as well as prevention and care policies and 
interventions.

Summary of the Award

    Recipient: IPCI.
    Purpose of the Award: The purpose of this award is to sustain 
decentralization of HIV-associated microbiology at regional hospitals 
and to expand interventions to additional regional hospitals. It will 
improve support to and the coordination of the TB and OIs laboratory 
network for quality assured diagnosis of TB/DR-TB, including smear 
microscopy (LED), Lipoarabinomannan Assay (LF-LAM) for the diagnosis 
and screening of active tuberculosis in people with HIV, solid and 
liquid culture, and molecular WHO-recommended diagnostic tests (LIPA, 
Xpert Ultra).
    Amount of Award: The approximate year 1 funding amount will be 
$1,000,000 in Federal Fiscal Year (FYY) 2022 funds, subject to the 
availability of funds. Funding amounts for years 2-5 will be set at 
continuation.
    Authority: Public Law 108-25 (the United States Leadership Against 
HIV AIDS, Tuberculosis and Malaria Act of 2003).
    Period of Performance: September 30, 2022 through September 29, 
2027.

    Dated: March 2, 2022.
Terrance Perry,
Chief Grants Management Officer, Centers for Disease Control and 
Prevention.
[FR Doc. 2022-04790 Filed 3-7-22; 8:45 am]
BILLING CODE 4163-18-P